How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 112, Issue 1, 2004, Pages 95-97

  Batorfi, Jozsef ^a   Vegh, Gyorgy ^a   Szepesi, Janos ^a   Szigetvari, Ivan ^a   Doszpod, Jozsef ^a   Fulop, Vilmos ^a  

^a National Health Center   (Hungary)

Author keywords

Complete and partial hydatidiform mole; Follow up; Gestational trophoblastic disease; hCG; Human chorionic gonadotropin

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RELAPSE; SCREENING; TROPHOBLASTIC TUMOR;

EID: 0346995419     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00274-4     Document Type: Article

References (15)

1. Seckl M.J., Fisher R.A., Salerno G., Rees H., Paradinas F.J., Foskett M.et al. Choriocarcinoma and partial hydatidiform moles. Lancet. 356:2000;36-39.
2. Mungan T., Kuscu E., Dabakoglu T., Senoz S., Ugur M., Cobanoglu O. Hydatidiform mole: clinical analysis of 310 patients. Int J Gynecol Obstet. 52:1996;233-236.
3. Kohorn E.I. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol. 59:1982;78-84.
4. Berkowitz R.S., Goldstein D.P. Chorionic tumors. New Engl J Med. 335:1996;1740-1748.
5. Bolis G., Belloni C., Bonazzi C., Mangili G., Presti M., Zanaboni F.et al. Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior. Tumori. 74:1988;93-96.
6. Lurain J.R., Brewer J.I., Torok E.E., Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 145:1983;591-595.
7. Soper J.T., Clarke-Pearson D., Hammond C.B. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. Obstet Gynecol. 71:1988;338-343.
8. Garner E.I.O., Lipson E., Bernstein M.R., Goldstein D.P., Berkowitz R.S. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 47:2002;380-386.
9. Woolas R.P., Bower M., Newlands E.S., Seckl M., Short D., Holden L. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol. 105:1998;1032-1035.
10. Massad L.S., Abu-Rustum N.R., Lee S.S., Renta V. Poor compliance with post-molar surveillance and treatment protocols by indigent women. Obstet Gynecol. 96:2000;940-944.
11. Schlaerth J.B., Morrow C.P., Kletzky O.A., Nalick R.H., D'Ablaing G.A. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Obstet Gynecol. 58:1981;478-482.
12. Kim D.S., Moon H., Kim K.T., Moon Y.J., Hwang Y.Y. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol. 67:1986;690-694.
13. Paradinas F.J., Browne P., Fisher R.A., Foskett M., Bagshawe K.D., Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology. 28:1996;101-110.
14. Rob L., Rovova H., Pluta M., Kulovany E., Hrehorcak M., Chmel R.et al. Regression of hCG in various types of molar pregnancies - clinical course and prognosis. Ceska Gynecol. 66:2001;230-235.
15. Feltmate C.M., Batorfi J., Fulop V., Goldstein D.P., Doszpod J., Berkowitz R.S. Human chorionic gonadotropin follow up in patients with molar pregnancy: a time for re-evaluation. Obstet Gynecol. 101:2003;732-736.